Canada's biosimilar sales 2009-2018
In 2017, the total biosimilar sales in Canada amounted to 60.8 million Canadian dollars, rising to 146.3 million dollars in 2018. The statistic illustrates the Canadian biosimilar sales form 2009 to 2018. Biosimilars are for biologic drugs, in fact, the same as generics for pharmaceuticals: after the patent of an original biologic drug expires, a highly similar product with the same level of safety and efficiency is allowed to enter the market under significantly lower prices.
